Navigation Links
Asthma & Allergy Foundation CEO Appointed to NIH Council
Date:1/9/2009

BETHESDA, Md., Jan. 10 /PRNewswire-USNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announces that its President and CEO, William M. McLin, has been appointed to the Council of the National Institute of Allergy and Infectious Disease (NIAID), an institute of the National Institutes of Health (NIH), for a four-year term. The Council is a chartered advisory committee that provides a diverse perspective on science, health and the human impact of diseases.

The Council serves as NIAID's main advisory body on key functions, including: performing peer review, advising on policy, reviewing programs, and developing and clearing concepts for program announcements, requests for applications and requests for proposals. NIAID often seeks the Council's advice before changing policies for training, health information dissemination, administration, budget and other areas.

McLin has been head of AAFA since 2001 at a time when asthma and allergic diseases in the U.S. have experienced alarming growth; prevalence has nearly doubled over the past 25 years. McLin helped the 55-year-old not-for-profit patient group transition into the 21st Century to better educate patients and caregivers, as well as advocate and conduct research for the asthma and allergy community.

McLin will serve on the advisory subcommittee of the Division of Allergy, Immunology, and Transplantation through October 31, 2012. During program reviews, the subcommittee advises on a program's effectiveness in meeting Institute goals and the needs of the allergy and immunology community.

Before coming to AAFA, McLin served as Director of Government Relations and Executive Vice President during his 20-year tenure with the Epilepsy Foundation of America. He also provided interim executive oversight services to numerous nonprofit organizations. Mr. McLin has held key positions with the National Health Council, the American Society of Association Executives, the President's Committee for Employment of People with Disabilities and the Public Advisory Roundtable of the American Thoracic Society.

NIAID conducts and supports basic and applied research to better understand, treat and prevent infectious, immunologic and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests and other technologies that have improved the health of millions of people around the world. Visit www.niaid.nih.gov.

AAFA is the leading national not-for-profit patient advocacy organization for people with asthma and allergies. It is dedicated to improving the quality of life for people with asthma and allergies through education, advocacy and research. For more information, visit www.aafa.org.


'/>"/>
SOURCE The Asthma and Allergy Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nitric Oxide Monitoring of Little Benefit for Kids Asthma
2. NO help: Nitric oxide monitoring does not help most children with asthma
3. American Asthma Foundation Announces Breakthrough Discovery
4. Antifungal Drug May Help Ease Asthma
5. Fungal pill could provide asthma relief for 150,000 UK sufferers
6. Anti-fungal drug offers great benefits to some with severe asthma
7. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients
8. School Program Helps Cut Asthma Risks
9. Antacid Medication in Pregnancy May Increase Childhood Asthma
10. Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant
11. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... Miami, Florida (PRWEB) , ... May 06, 2016 , ... ... scratching their heads as they try to get rid of the bugs and keep ... left trying to figure out how to protect their kids and their homes from ...
(Date:5/6/2016)... Irving, TX (PRWEB) , ... May 06, 2016 ... ... from offices in Irving, TX has announced the latest beneficiary of their ongoing ... a local family battling childhood leukemia. Young Mason McGaughey faces many more months ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... of a master charity program created to support and assist the people of ... days, working closely with nonprofit organizations and community leaders. Their desire is to ...
(Date:5/6/2016)... and LONDON, UK (PRWEB) , ... May 06, 2016 , ... ... for his success in changing the way the pharmaceutical industry conducts clinical trials. This ... the world’s most influential people in pharma, and he was honored as a Tech ...
(Date:5/6/2016)... ... , ... The joy associated with Mother’s Day is mixed with worry and fear for new ... across the country. For the first time ever, the March of Dimes and ... their Mother’s Day beside a crib surrounded by lifesaving equipment or peering through a glass ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... -- Endo International plc (NASDAQ: ENDP ) ... , President, U.S. Branded Pharmaceuticals, has decided to ... of a successor. Mr. Lortie joined Endo in ... responsibility for all strategic, commercial and operational functions, ... commercial operations, managed markets, manufacturing, supply chain and ...
(Date:5/5/2016)... , First quarter 2016 adjusted diluted earnings per share ... , First quarter reported diluted (GAAP) loss per share ... revises 2016 financial guidance; now expects 2016 revenues to range ... non-GAAP earnings per share to range from $4.50 to $4.80 ... and manufacturing facility restructuring , Company expands ...
(Date:5/5/2016)... , May 5, 2016  Diagnostic imaging has ... due to concerns that these tests cause health care costs ... to imaging, as well as the adoption of ... of medical peripherals that help health care providers cut costs, ...  advanced medical imaging is a renowned authorized reseller of ...
Breaking Medicine Technology: